Clinical Trial Update: A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of PRCL-02 in moderate to severe chronic plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis Vulgaris

Drugs mentioned

• PRCL-02

Snippet

Sponsor: PRCL Research Inc. | Conditions: Psoriasis Vulgaris, Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2020-03-30